{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:44:45Z","timestamp":1787499885091,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["112-S0224"],"award-info":[{"award-number":["112-S0224"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["114-S0288"],"award-info":[{"award-number":["114-S0288"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC113-2320-B-002-002"],"award-info":[{"award-number":["NSTC113-2320-B-002-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC112-2320-B-008"],"award-info":[{"award-number":["NSTC112-2320-B-008"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC111-2320-B-002-058"],"award-info":[{"award-number":["NSTC111-2320-B-002-058"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.biopha.2025.118689","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T02:28:10Z","timestamp":1761618490000},"page":"118689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitors"],"prefix":"10.1016","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1523-3984","authenticated-orcid":false,"given":"Chi-Yang","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-2961","authenticated-orcid":false,"given":"Yu-Hsuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8368-1141","authenticated-orcid":false,"given":"Da-Liang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-An","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiung-Fei","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-In","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2025.118689_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3324\/haematol.2022.280801","article-title":"The clinical impact of the molecular landscape of acute myeloid leukemia","volume":"108","author":"Kayser","year":"2023","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib2","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.3390\/ijms21082907","article-title":"The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells","volume":"21","author":"Nepstad","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2025.118689_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signaling pathways in acute myeloid leukemia","volume":"95","author":"Sophie","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.biopha.2025.118689_bib5","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1182\/blood-2018-99-117485","article-title":"Phase 2 trial of single agent gedatolisib (PF-05212384), a dual PI3K\/mTOR inhibitor, for adverse prognosis and Relapse\/Refractory AML: clinical and transcriptomic results","volume":"132","author":"Vargaftig","year":"2018","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.biopha.2025.118689_bib6","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood-2013-11-535047","article-title":"Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110\u03b4, for relapsed\/refractory chronic lymphocytic leukemia","volume":"123","author":"Brown","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40360-020-00446-x","article-title":"A phase I study of a dual PI3-kinase\/mTOR inhibitor BEZ235 in adult patients with relapsed or refractory acute leukemia","volume":"21","author":"Lang","year":"2020","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib8","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-13-1978","article-title":"Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia","volume":"20","author":"Konopleva","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.biopha.2025.118689_bib9","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1182\/blood-2014-03-559963","article-title":"The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma","volume":"124","author":"Spencer","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.biopha.2025.118689_bib10","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.3390\/jcm9092934","article-title":"Targeting PI3K\/Akt\/mTOR in AML: rationale and clinical evidence","volume":"9","author":"Darici","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.biopha.2025.118689_bib11","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41417-023-00675-2","article-title":"Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K\/AKT\/mTOR signaling and suppression of mitochondrial biogenesis","volume":"30","author":"Tseng","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"17","key":"10.1016\/j.biopha.2025.118689_bib12","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118689_bib14","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"Featurecounts: an efficient general-purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.biopha.2025.118689_bib15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"issue":"W1","key":"10.1016\/j.biopha.2025.118689_bib16","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"43","key":"10.1016\/j.biopha.2025.118689_bib17","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118689_bib20","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/sj.leu.2404331","article-title":"A novel fluorescence-based multiplex PCR assay for rapid simultaneous detection of CEBPA mutations and NPM mutations in patients with acute myeloid leukemias","volume":"20","author":"Lin","year":"2006","journal-title":"Leukemia"},{"issue":"W1","key":"10.1016\/j.biopha.2025.118689_bib21","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118689_bib22","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118689_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2016.09.009","article-title":"A new view into the regulation of purine metabolism: the purinosome","volume":"42","author":"Pedley","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.chembiol.2016.11.013","article-title":"Rational design of selective allosteric inhibitors of PHGDH and serine synthesis with anti-tumor activity","volume":"24","author":"Wang","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118689_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nchembio.2070","article-title":"A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate","volume":"12","author":"Pacold","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118689_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00999399","article-title":"Inhibition of the 6-phosphogluconate dehydrogenase in the rat kidney by 6-aminonicotinamide","volume":"267","author":"Lange","year":"1970","journal-title":"NaunynSchmiede Arch. F. \u00fcR. Pharmakol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118689_bib27","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.bmcl.2007.11.101","article-title":"Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors","volume":"18","author":"Thomas","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"22","key":"10.1016\/j.biopha.2025.118689_bib28","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1182\/bloodadvances.2022007563","article-title":"Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML","volume":"6","author":"Pianigiani","year":"2022","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2017-08-797886","article-title":"Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and waldenstrom macroglobulinemia","volume":"131","author":"Chen","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-022-01319-y","article-title":"Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents","volume":"15","author":"Lee","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118689_bib31","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI66343","article-title":"RSK3\/4 mediate resistance to PI3K pathway inhibitors in breast cancer","volume":"123","author":"Serra","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2010.10.031","article-title":"AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity","volume":"19","author":"Chandarlapaty","year":"2011","journal-title":"Cancer Cell"},{"issue":"7538","key":"10.1016\/j.biopha.2025.118689_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nature13948","article-title":"Convergent loss of PTEN leads to clinical resistance to a PI(3)K\u03b1 inhibitor","volume":"518","author":"Juric","year":"2015","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2025.118689_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fendo.2020.00365","article-title":"The role of the pentose phosphate pathway in diabetes and cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118689_bib36","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ncb2789","article-title":"TAp73 enhances the pentose phosphate pathway and supports cell proliferation","volume":"15","author":"Du","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118689_bib37","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1038\/ncomms9468","article-title":"O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth","volume":"6","author":"Rao","year":"2015","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.biopha.2025.118689_bib38","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2017.81","article-title":"High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells","volume":"31","author":"Poulain","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2025.118689_bib39","article-title":"SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation","volume":"6","author":"Xu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41467-019-08921-8","article-title":"Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2025.118689_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tibs.2014.02.004","article-title":"Serine and glycine metabolism in cancer","volume":"39","author":"Amelio","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118689_bib42","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1158\/2159-8290.CD-14-0250","article-title":"Serine catabolism regulates mitochondrial redox control during hypoxia","volume":"4","author":"Ye","year":"2014","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cmet.2020.12.005","article-title":"High fructose drives the serine synthesis pathway in acute myeloid leukemic cells","volume":"33","author":"Jeong","year":"2021","journal-title":"Cell Metab."},{"issue":"13","key":"10.1016\/j.biopha.2025.118689_bib44","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.molcel.2021.05.008","article-title":"ATF3 coordinates serine and nucleotide metabolism to drive cell cycle progression in acute myeloid leukemia","volume":"81","author":"Di Marcantonio","year":"2021","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.biopha.2025.118689_bib45","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/2159-8290.CD-20-0738","article-title":"Serine biosynthesis is a metabolic vulnerability in FLT3-ITD-Driven acute myeloid leukemia","volume":"11","author":"Bjelosevic","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2025.118689_bib47","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.7150\/jca.90822","article-title":"PHGDH is key to a prognostic multigene signature and a potential therapeutic target in acute myeloid leukemia","volume":"15","author":"Zhong","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2025.118689_bib48","article-title":"PHGDH inhibitor CBR-5884 inhibits epithelial ovarian cancer progression via ROS\/Wnt\/\u03b2-Catenin pathway and plays a synergistic role with PARP inhibitor olaparib","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"issue":"14","key":"10.1016\/j.biopha.2025.118689_bib49","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40164-020-00196-w","article-title":"Targeting phosphoglycerate dehydrogenase in multiple myeloma","volume":"10","author":"Elsaadi","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.biopha.2025.118689_bib51","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1158\/0008-5472.CAN-17-1589","article-title":"PHGDH as a key enzyme for serine biosynthesis inHIF2\u03b1-targeting therapy for renal cell carcinoma","volume":"77","author":"Yoshino","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-021-00474-4","article-title":"Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?","volume":"7","author":"McNamee","year":"2021","journal-title":"Cell Death Discov."},{"issue":"13","key":"10.1016\/j.biopha.2025.118689_bib53","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s40265-019-01188-9","article-title":"Selinexor: first global approval","volume":"79","author":"Syed","year":"2019","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.biopha.2025.118689_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-022-01319-y","article-title":"Oral eltanexor treatment of patients with higher-risk myelodysplastic syndrome refractory to hypomethylating agents","volume":"15","author":"Lee","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118689_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41571-020-00442-4","article-title":"The nuclear export protein XPO1 \u2014 from biology to targeted therapy","volume":"18","author":"Azmi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118689_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/0008-5472.CAN-23-1992","article-title":"XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells","volume":"84","author":"Marullo","year":"2024","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118689_bib57","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.it.2022.07.004","article-title":"NF-kB: blending metabolism, immunity, and inflammation","volume":"43","author":"Capece","year":"2022","journal-title":"Trends Immunol."},{"issue":"S1","key":"10.1016\/j.biopha.2025.118689_bib58","first-page":"3266","article-title":"Combination of selinexor with PI3K\/mTOR dual inhibitor omipalisib exhibits synergistic effects in acute myeloid cells with different genetic background invitro and in vivo","volume":"8","author":"Lin","year":"2024","journal-title":"HemaSphere"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225008832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:23:35Z","timestamp":1775780615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225008832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"alternative-id":["S0753332225008832"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118689","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting serine metabolism vulnerability in omipalisib-resistant acute myeloid leukemia with phosphoglycerate dehydrogenase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118689"}}